In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and more.
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the next generation of engineered T cells.
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond colonoscopies.
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast cancer.
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.
What does a naked mole rat, a nuclear exporter that “moonlights” as a chromatin regulator, and the combined power of tissue and liquid biopsy all have in common? They are all at the heart...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More